Treatment of Acute Gout
First-line treatment for acute gout should be initiated within 24 hours of symptom onset using NSAIDs, oral colchicine, or corticosteroids, with medication selection based on patient comorbidities and joint involvement. 1
First-Line Treatment Options
NSAIDs
- Use full FDA-approved anti-inflammatory doses until attack resolves 1
- Example: Naproxen at anti-inflammatory doses
- Contraindications: Avoid in patients with cardiovascular disease, heart failure, peptic ulcer disease, or renal failure 1, 2
- NSAIDs with short plasma half-lives (diclofenac, ketoprofen) are preferred in elderly patients 3
Colchicine
- Low-dose regimen: 1.2 mg at first sign of flare, followed by 0.6 mg one hour later 1
- Advantages: Safe in cardiovascular disease and may reduce risk of myocardial infarction 2
- Dose adjustments:
- Poorly tolerated in elderly patients - use with caution 3
Corticosteroids
- Oral prednisone: 0.5 mg/kg per day for 5-10 days at full dose then stop, or 2-5 days at full dose followed by 7-10 day taper 1
- Intra-articular corticosteroids: Dose varies by joint size 1
- Intramuscular triamcinolone acetonide 60 mg, followed by oral prednisone 1
- First choice in patients with renal disease, heart failure, cirrhosis, or contraindications to NSAIDs/colchicine 1
- Short durations of low-dose glucocorticoids are efficacious and may be safe in patients with cardiovascular disease 2
Treatment Selection Algorithm
For patients with renal disease, heart failure, or cirrhosis:
For patients with cardiovascular disease:
For patients with diabetes or uncontrolled hypertension:
For patients with GI issues or history of ulcers:
For severe or polyarticular attacks:
Important Clinical Considerations
- Timing is critical: Initiate treatment within 24 hours of symptom onset for optimal results 1
- Do not interrupt ongoing urate-lowering therapy during an acute attack 1
- Prophylaxis: When initiating urate-lowering therapy, provide prophylaxis with low-dose colchicine (0.6 mg/day) or low-dose NSAIDs for 3-6 months to prevent flares 1, 5
- Monitoring: Watch for adverse effects with longer-term use, particularly with corticosteroids (dysphoria, mood disorders, elevated blood glucose, immune suppression) 1
Common Pitfalls to Avoid
- Delaying treatment beyond 24 hours of symptom onset 1
- Interrupting urate-lowering therapy during acute attacks 1
- Using high-dose colchicine regimens (associated with more adverse effects) 6
- Failing to consider patient comorbidities when selecting therapy 1
- Overlooking the need for prophylaxis when initiating urate-lowering therapy 1, 5
Moderate-certainty evidence shows that systemic glucocorticoids and NSAIDs are probably equally beneficial for pain relief, but NSAIDs likely result in more total adverse events 7, 6. Low-dose colchicine is as effective as high-dose but with fewer adverse events 6.